TCEA1P2: A Potential Drug Target and Biomarker for Transcription Elongation Factor A1 Pseudogene 2

Target Name: TCEA1P2

NCBI ID: G399511

TCEA1P2

Other Name(s): transcription elongation factor A1 pseudogene 2 | Transcription elongation factor A1 pseudogene 2

TCEA1P2: A Potential Drug Target and Biomarker for Transcription Elongation Factor A1 Pseudogene 2

Introduction

Transcription elongation factor A1 pseudogene 2 (TCEA1P2) is a non-coding RNA molecule that plays a crucial role in the regulation of gene expression. It is a key regulator of the T-cell receptor (TCR), which is responsible for cell survival and division in the immune system. TCEA1P2 has been identified as a potential drug target and biomarker due to its unique structure, function, and potential therapeutic applications.

Structure and Function

TCEA1P2 is a small non-coding RNA molecule that contains 198 amino acid residues. It has a unique open-loop structure, with a 5'-end that is conserved in various species, but a 3'-end that is highly conserved across different organisms. The 3'-end of TCEA1P2 contains a unique extension, known as the N-terminal hypervariable region (HVR), which is responsible for its unique function and structure.

The N-terminal HVR of TCEA1P2 is rich in conserved secondary structure, such as a stem-loop, a 尾-sheet, and a loop. The stem-loop is a common structural element that is involved in the regulation of various cellular processes , including cell signaling pathways. The 尾-sheet is a structural element that is involved in the regulation of protein structure and function. The loop is a structural element that is involved in the regulation of various cellular processes, including cell signaling pathways.

TCEA1P2 functions as a transcription elongation factor by binding to specific DNA sequences and promoting the extension of the 3'-end of target transcripts. It has been shown that TCEA1P2 can enhance the stability of the 3'-end of target transcripts and increase their translation efficiency. TCEA1P2 has also been shown to play a role in the regulation of cellular processes, including cell growth, apoptosis, and inflammation.

Potential Drug Target

TCEA1P2 has been identified as a potential drug target due to its unique structure and function. The N-terminal HVR of TCEA1P2 is rich in conserved secondary structure, which makes it a potential target for small molecules. Additionally, TCEA1P2 functions as a transcription elongation factor, which means that it can be a useful biomarker for tracking the effects of drugs on gene expression.

TCEA1P2 has been shown to be highly expressed in various tissues and cells, including T cells, B cells, and cancer cells. It has also been shown to play a role in the regulation of cellular processes, including cell growth, apoptosis, and inflammation. This suggests that TCEA1P2 may be a useful target for small molecules that can modulate its function and have therapeutic applications.

Biomarker Potential

TCEA1P2 has the potential to serve as a biomarker for various diseases, including cancer. Cancer is a disease that is characterized by the uncontrolled growth and division of cells. This can lead to the formation of tumors, which can be deadly if left untreated. TCEA1P2 has been shown to play a role in the regulation of cellular processes, including cell growth, apoptosis, and inflammation. This suggests that TCEA1P2 may be a useful biomarker for tracking the effects of drugs on cancer cell growth and proliferation.

In addition to its potential as a biomarker, TCEA1P2 has the potential to serve as a drug target. The N-terminal HVR of TCEA1P2 is rich in conserved secondary structure, which makes it a potential target for small molecules. Additionally, TCEA1P2 functions as a transcription elongation factor, which means that it can be a useful target for drugs that can modulate its function.

Conclusion

TCEA1P2 is a unique non-coding RNA molecule that plays a crucial role in the regulation of gene expression. It has a unique open-loop structure and a 3'-end that is highly conserved across different organisms. The N-terminal HVR of TCEA1P2 is rich in conserved secondary structure, which makes it a potential target for small molecules. Additionally, TCEA1P2 functions as a transcription elongation factor, which means that it can be a useful target for drugs that can modulate its function. These properties make TCEA1P2 a potential drug target and biomarker for various diseases, including cancer. Further research is needed to fully understand the functions of TCEA1P2 and its potential as a drug.

Protein Name: Transcription Elongation Factor A1 Pseudogene 2

The "TCEA1P2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TCEA1P2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets